Skip to content

Clinical trials

Recruiting Lung Diseases, Interstitial trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Recruiting Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20232
20243
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Boehringer Ingelheim2
AllRock Bio, Inc.1
Contineum Therapeutics1
Insmed Incorporated1
Liquidia Technologies, Inc.1
Rein Therapeutics1
The University of Western Australia1
United Therapeutics1
University of Massachusetts, Worcester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial14
Hypertension, Pulmonary3
Pulmonary Fibrosis3
Connective Tissue Diseases2
Idiopathic Pulmonary Fibrosis2
Scleroderma, Diffuse2
Autoimmune Diseases1
Chronic Disease1
Hereditary Sensory and Autonomic Neuropathies1
Lung Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.